Irradiation combined with SU5416: Microvascular changes and growth delay in a human xenograft glioblastoma tumor line

被引:22
作者
Schuuring, J
Bussink, J
Bernsen, HJJA
Peeters, W
van Der Kogel, AJ
机构
[1] Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands
[3] Groene Hart Hosp, Dept Neurol, Gouda, Netherlands
[4] Canisius Wilhelmina Hosp, Nijmegen, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 61卷 / 02期
关键词
glioblastoma; irradiation; antiangiogenesis; vascularity;
D O I
10.1016/j.ijrobp.2004.09.063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The combination of irradiation and the antiangiogenic compound SU5416 was tested and compared with irradiation alone in a human glioblastoma tumor line xenografted in nude mice. The aim of this study was to monitor microenvironmental changes and growth delay. Methods and Materials: A human glioblastoma xenograft tumor line was implanted in nude mice. Irradiations consisted of 10 Gy or 20 Gy with and without SU5416. Several microenvironmental parameters (tumor cell hypoxia, tumor blood perfusion, vascular volume, and microvascular density) were analyzed after imunohistochemical staining. Tumor growth delay was monitored for up to 200 days after treatment. Results: SU5416, when combined with irradiation, has an additive effect over treatment with irradiation alone. Analysis of the tumor microenvironment showed a decreased vascular density during treatment with SU5416. In tumors regrowing after reaching only a partial remission, vascular characteristics normalized shortly after cessation of SU5416. However, in tumors regrowing after reaching a complete remission, permanent microenvironmental changes and an increase of tumor necrosis with a subsequent slower tumor regrowth was found. Conclusions: Permanent vascular changes were seen after combined treatment resulting in complete remission. Antiangiogenic treatment with SU5416 when combined with irradiation has an additive effect over treatment with irradiation or antiangiogenic treatment alone. (C) 2005 Elsevier Inc.
引用
收藏
页码:529 / 534
页数:6
相关论文
共 17 条
[1]   Development of inhibitors for protein tyrosine kinases [J].
Al-Obeidi, FA ;
Lam, KS .
ONCOGENE, 2000, 19 (49) :5690-5701
[2]   INHALATION ANESTHESIA IN EXPERIMENTAL RADIOTHERAPY - A RELIABLE AND TIME-SAVING SYSTEM FOR MULTIFRACTIONATION STUDIES IN A CLINICAL DEPARTMENT [J].
ANG, KK ;
VANDERKOGEL, AJ ;
VANDERSCHUEREN, E .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (01) :145-148
[3]  
Angelov L, 1999, CANCER RES, V59, P5536
[4]  
[Anonymous], 2000, Pathology and Genetics of Tumours of the Nervous System
[5]  
BEGG AC, 1987, RODENT TUMOR MODELS, P114
[6]  
BUSSINK J, 2000, RADIAT RES, V4, P398
[7]   RESECTION, BIOPSY, AND SURVIVAL IN MALIGNANT GLIAL NEOPLASMS - A RETROSPECTIVE STUDY OF CLINICAL-PARAMETERS, THERAPY, AND OUTCOME [J].
DEVAUX, BC ;
OFALLON, JR ;
KELLY, PJ .
JOURNAL OF NEUROSURGERY, 1993, 78 (05) :767-775
[8]   Fighting cancer by attacking its blood supply [J].
Folkman, J .
SCIENTIFIC AMERICAN, 1996, 275 (03) :150-+
[9]  
Fong TAT, 1999, CANCER RES, V59, P99
[10]  
Geng L, 2001, CANCER RES, V61, P2413